Root Financial Partners’s Sagimet Biosciences SGMT Stock Holding History

Root Financial Partners’s Portfolio SGMT Stock Details SGMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$296	Buy	+30	New	+$276	﹤0.01%	3411

Other funds holding SGMT

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

ACPLP

ACT Capital Partners, L.P. Wayne, Pennsylvania $154M AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Root Financial Partners's SGMT Position: Q3 2026 in Review

Root Financial Partners opened a new position in Sagimet Biosciences (SGMT) in Q3 2026: 30 shares worth $296. The stake represents ﹤0.01% of the portfolio and ranks #3411 among its holdings.

34 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.

Root Financial Partners held 30 shares of Sagimet Biosciences worth $296 as of Q3 2026.
Sagimet Biosciences was a new Root Financial Partners position in Q3 2026.
Sagimet Biosciences made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3411 holding.
34 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.